US patent for miniature diagnostics technology:
This article was originally published in Clinica
Executive Summary
The University of Washington has received a US patent covering a chemical component separation technology, which could lead to the development of small, portable, easy-to-use medical diagnostic devices capable of performing a wide variety of tests using less than a drop of blood. The H-Filters technique can be used as part of microfluid integrated circuits to separate small soluble components from larger particles. The new method, which could replace the cumbersome and time-consuming centrifugation steps needed for most blood tests, is being commercialised under an exclusive license by Micronics, the Redmond, Washington-based developer of microfluid technologies.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.